Randomized, double-blinded, controlled clinical trial of the effect of captopril, telmisartan and their combination on systemic inflammation of patients on hemodialysis

To evaluate individual and combined effect of captopril and telmisartan on systemic inflammation markers of hemodialysis (HD) patients. Randomized, double-blinded, controlled clinical trial. Patients on HD at least 2 months, with arteriovenous fistula, were randomly allocated to groups: (1) captopri...

Descripción completa

Detalles Bibliográficos
Autores principales: Ordaz-Medina, Susan M., Cueto-Manzano, Alfonso M., González-Plascencia, Juana, Montañez-Fernández, José L., Ordaz-Medina, Elias J., Martín-del-Campo, Fabiola, Cueto-Ramírez, Alfonso M., Martínez-Martínez, Petra, Cortés-Sanabria, Laura, Rojas-Campos, Enrique, Trujillo-Hernández, Benjamín
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9584892/
https://www.ncbi.nlm.nih.gov/pubmed/36266534
http://dx.doi.org/10.1038/s41598-022-22656-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9584892/
https://www.ncbi.nlm.nih.gov/pubmed/36266534
http://dx.doi.org/10.1038/s41598-022-22656-5

Ejemplares similares